Arlinghaus RB - Search Results

1

Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon.

Oka T, Sastry KJ, Nehete P, Schapiro SJ, Guo JQ, Talpaz M, Arlinghaus RB. Oka T, et al. Among authors: arlinghaus rb. Leukemia. 1998 Feb;12(2):155-63. doi: 10.1038/sj.leu.2400919. Leukemia. 1998. PMID: 9519777 Clinical Trial.

2

Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization.

Seong D, Kantarjian HM, Albitar M, Arlinghaus R, Xu J, Talpaz M, Rios MB, Guo JQ, O'Brien S, Siciliano M. Seong D, et al. Ann Oncol. 1999 Aug;10(8):955-9. doi: 10.1023/a:1008349405763. Ann Oncol. 1999. PMID: 10509158 Free article.

3

Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL.

Lu D, Liu J, Campbell M, Guo JQ, Heisterkamp N, Groffen J, Canaani E, Arlinghaus R. Lu D, et al. Blood. 1993 Aug 15;82(4):1257-63. Blood. 1993. PMID: 8353288 Free article.

4

Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemia.

Bseiso AW, Kantarjian HM, Guo JQ, Cortes J, Talpaz M, Koller C, AlBitar M, Keating M, Arlinghaus R. Bseiso AW, et al. Leukemia. 1997 Sep;11(9):1583-7. doi: 10.1038/sj.leu.2400752. Leukemia. 1997. PMID: 9305617

5

Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients.

Guo JQ, Lian J, Glassman A, Talpaz M, Kantarjian H, Deisseroth AB, Arlinghaus RB. Guo JQ, et al. Among authors: arlinghaus rb. Am J Clin Pathol. 1996 Oct;106(4):442-8. doi: 10.1093/ajcp/106.4.442. Am J Clin Pathol. 1996. PMID: 8853030

6

Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia.

Schenk TM, Keyhani A, Bottcher S, Kliche KO, Goodacre A, Guo JQ, Arlinghaus RB, Kantarjian HM, Andreeff M. Schenk TM, et al. Among authors: arlinghaus rb. Leukemia. 1998 May;12(5):666-74. doi: 10.1038/sj.leu.2400986. Leukemia. 1998. PMID: 9593263

7

Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.

Guo JQ, Lin H, Kantarjian H, Talpaz M, Champlin R, Andreeff M, Glassman A, Arlinghaus RB. Guo JQ, et al. Among authors: arlinghaus rb. Leukemia. 2002 Dec;16(12):2447-53. doi: 10.1038/sj.leu.2402730. Leukemia. 2002. PMID: 12454751

8

Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.

Guo JQ, Wang JY, Arlinghaus RB. Guo JQ, et al. Among authors: arlinghaus rb. Cancer Res. 1991 Jun 1;51(11):3048-51. Cancer Res. 1991. PMID: 2032243

9

Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy.

Atallah E, Talpaz M, O'brien S, Rios MB, Guo JQ, Arlinghaus R, Fernandes-Reese S, Kantarjian H. Atallah E, et al. Cancer. 2002 Jun 1;94(11):2996-9. doi: 10.1002/cncr.10576. Cancer. 2002. PMID: 12115389 Free article.

10

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

Donato NJ, Wu JY, Stapley J, Gallick G, Lin H, Arlinghaus R, Talpaz M. Donato NJ, et al. Blood. 2003 Jan 15;101(2):690-8. doi: 10.1182/blood.V101.2.690. Blood. 2003. PMID: 12509383 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters